Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.22.4
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]    
Revenues $ 2,507,794 $ 14,135,132
FC2 [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 2,500,001 14,135,132
FC2, U.S. Prescription Channel [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 163,004 11,574,266
FC2, Global Public Health Sector [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 2,336,997 $ 2,560,866
ENTADFI [Member]    
Disaggregation of Revenue [Line Items]    
Revenues $ 7,793